TruthArchive.ai - Related Video Feed

In this video, the speaker discusses the absence of autism in Vietnam in the past. They mention that when Vietnam joined the World Health Organization and the International Monetary Fund, Bill Gates and the Gates Foundation introduced a vaccination program. As a result, Vietnam now has a high vaccination rate of over 300%.

The speaker discusses a WHO meeting in December 2019 where vaccine safety was questioned. It was revealed that there is no scientific proof that vaccines are safe and effective when used together. This realization exposed a 100-year bluff, leaving many concerned about the lack of evidence for vaccine safety. The cost and affordability of vaccines were also highlighted as a significant issue for families.

The speaker discusses the world's population and the potential to lower it through vaccines and healthcare. They mention the use of lipid nanoparticles to create factories for vaccine production. The importance of vaccines is emphasized, especially for diseases without a vaccine. The speaker acknowledges the issue of vaccine hesitancy, particularly in developing countries, and the misinformation surrounding vaccines. They mention the tragedy of millions of deaths and the need to move on. The conversation concludes with a mention of preparing for the future and rejecting the idea that vaccines cause harm.

Speaker 0 discusses the development, adoption, and scaling of vaccines for different variants and subvariants. Speaker 1 highlights the positive progress made in terms of manufacturing capacity. They recall a conversation where they discussed the need to produce a billion vaccines in response to a predicted pandemic.

Speaker 0 describes a highly significant and controversial issue surrounding human papillomavirus (HPV) vaccines, including Gardasil and Cervarix, and reports that lawsuits are occurring worldwide. In Japan, there have been major lawsuits with hundreds of plaintiffs, including young women and girls, though the fundamental problem, according to the speaker, centers on contamination with DNA impurities. The speaker states that from the early days of the Ministry of Health, Labour and Welfare in Japan, the core issue has been the contamination with DNA impurities in vaccines, and that this problem had already become clear by 2012 in a widely cited paper. The speaker explains that by 2012, a paper described the DNA contamination in Gardasil-related vaccines, specifically noting residual DNA fragments from HPV types 16 and 18 associated with the vaccine’s aluminum adjuvant particles. The claim is that vaccine samples contained residual HPV DNA fragments that were directly bound to aluminum adjuvant particles, and that PCR tests confirmed these DNA fragments were identical to the HPV sequences described in the paper. The speaker emphasizes that researchers around the world—doctors and researchers listening to women and girls’ voices—noticed unusual, severe post-vaccination symptoms in children and young women, and saw potential links between these symptoms and the residual HPV DNA attached to adjuvants. The testimony references samples gathered from multiple countries (Australia, Bulgaria, France, India, New Zealand, Poland, Russia, Spain, and the United States) and asserts that nearly all of the Gardasil/HPV vaccine lots examined contained residual HPV DNA attached to aluminum adjuvant particles. The speaker mentions that in the specific investigation, sixteen samples of Gardasil-4 contained residual HPV DNA fragments bound to aluminum adjuvant particles, and that all samples tested via PCR showed the same DNA sequence as described in the 2012 paper. The speaker claims that in 2014, the vaccine program for cervical cancer halted in Japan, and that the subsequent attention brought this issue to light publicly. The discussion attributes the major role to a Japanese expert, Ishii Ken (Ishii-sensei), described as a leading figure in Japan’s vaccine adverse-event research. The speaker recounts that, in the years around 2012–2014, efforts involved international collaboration with HR/HSA, FDA, and others, although logistical obstacles caused delays. The speaker notes that in 2012, 16 vaccine packages were distributed in nine countries for examination and that contamination persisted in all samples. They credit Japan with acting as a global relay for disseminating information about DNA contamination and its potential health implications. Further, the speaker references a broader context: the later emergence of literature discussing how DNA contamination might relate to adverse neurological or systemic symptoms, and the evolution of guidelines on acceptable residual DNA in vaccines. The discussion mentions that WHO and FDA guidelines permit changing permissible DNA limits over time, with higher thresholds introduced for manufacturing and regulatory purposes, raising questions about what constitutes safety and what is permissible in drug development. The dialogue closes with Speaker 1 alluding to the seriousness of the issue, noting deaths in the context of messenger-type vaccines and subsequent debates about vaccine safety, while acknowledging that those opposed to this view are also active.

Bill Gates and the WHO have promoted the DTP vaccine, but the speaker claims it was withdrawn in the 1980s in the US due to causing brain damage, according to an NIH/UCLA study, and replaced with a safer but less effective DTaP vaccine. The speaker alleges that while essentially banned for white children worldwide, Gates and the WHO gave it to African and Asian children. The Danish government requested a study proving the vaccine saved lives, but Gates was allegedly unable to provide one. A Danish study in Africa, examining 30 years of vaccination records, purportedly found that girls who received the DTP vaccine were 10 times more likely to die than unvaccinated children, not from the targeted diseases, but from conditions like anemia, bilharzia, malaria, dysentery, and pneumonia. The speaker concludes that the vaccine was killing more people than the diseases it was intended to prevent. The speaker asserts this issue stems from a lack of placebo-controlled trials in vaccinology.

Speaker 0 discusses the development, adoption, and scaling of vaccines for different variants and subvariants. They highlight the concern surrounding this issue and the context of the discussion. Speaker 1 shares the good news that there is now manufacturing capacity for vaccines. They recall a conversation where they expressed the need to produce a billion vaccines in the following year due to the pandemic.

Vaccines eradicated smallpox and polio. The speaker was taught that vaccines are safe, effective, and necessary, and there's no reason to question it. Medical school rotations reinforced that vaccines are safe and effective, and the speaker was told to ignore the inserts because that's lawyer jargon. Medical school provided no education about vaccine contents, safety records, informed consent, or the vaccine injury compensation program. The speaker assumed the science was settled and didn't question vaccines.

I spoke with Pfizer's CEO, Albert Bourla, about the approval process. We discussed vaccine safety and serious side effects. Many companies and institutions are embracing the COVID vaccine due to its effectiveness. Logistics are crucial in this process. Translation (if needed): I talked to Pfizer's CEO, Albert Bourla, about the approval process. We talked about vaccine safety and serious side effects. Many companies and institutions are adopting the COVID vaccine because it works well. Logistics are important in this situation.

The speaker claims that when the rotavirus vaccine was approved, four out of five board members had direct financial interests in it, working for the companies that made the vaccine or receiving grants to do clinical trials on it. One board member, Paul Offit, allegedly voted to add the rotavirus vaccine to the schedule while he had a rotavirus vaccine in development. The speaker says that because it's now on the schedule, his developing vaccine is virtually guaranteed to get on the schedule. The rotavirus vaccine that Offit voted on was withdrawn within a year because it was causing intussusception in kids. Offit's vaccine then replaced it. The speaker states that Offit and his business partners sold that vaccine to Merck for $186,000,000. The speaker says that Offit told Newsweek that he won the lottery and that it's been said of him that he voted himself rich.

Speaker 0 discusses the development, adoption, and scaling of vaccines for different variants and subvariants. Speaker 1 highlights the positive progress made in terms of manufacturing capacity. They recall a conversation where they discussed the need to produce a billion vaccines due to the predicted pandemic.

Speaker 0 describes the plasma-derived hepatitis B vaccine as derived from “the most dangerous starting material” and asserts the starting material was blood heavily contaminated with HIV, collected from New York heroin users during what is recognized as the world’s first AIDS outbreak. He notes the vaccine’s development began with funds from Doctor Fauci’s agency, in collaboration with Tuskegee researchers, to cross-connect arteries of tranquillised chimpanzees and comatose humans, with mixed raw blood flowing between groups of chimps and humans to train the chimps’ immune systems on human hepatitis virus. The vaccine inventors warned it might work the other way as well and claims several chimpanzees tested positive for ancestors to HIV and Kaposi’s sarcoma herpes virus, the deadly combination behind AIDS; this serial passage between species is called gain of function. He concludes this created the safest vaccine we’ve ever used. Speaker 1 adds a claim about a hidden starting point: the blood used was heavily contaminated with HIV from New York heroin users, and that the vaccine’s development involved financing from Fauci’s agency and collaboration with Tuskegee researchers to cross-link chimpanzee and human circulatory systems. He states that the serial passage of viruses between species is now called gain of function and asserts this process produced HIV and Kaposi’s sarcoma herpes virus, and suggests the vaccine’s safety is paradoxical given these origins. Speaker 2 emphasizes responsibility and risk, noting AIDS’ cause was unknown at the time but fear centered on potential contamination of the vaccine with whatever caused AIDS. HIV was “sort of hanging over this vaccine like a cloud,” though he claims HIV couldn’t survive the treatments given to the vaccine. Speaker 0 transitions to Part II, a deep dive into the vaccine timeline, aiming to quickly reach the AIDS timeline ramifications. Speaker 3 provides a timeline framework: well-documented events through May 1983 to set the stage for two fiercely contested events now resolved by a federal investigation. Speaker 2 lists milestones: - 1950s: The world’s earliest confirmed HIV-positive being is a chimpanzee used to develop hepatitis B vaccines. - 1960s: Chimpanzees and New York heroin users cross-transfuse raw blood to generate chimpanzee antigens to fight human hepatitis. - 1972: Scientists at Doctor Fauci’s agency announce chimpanzee antigens protect humans from hepatitis B; first patent filed for a human vaccine made from chimpanzee antigens. - 1973: The world’s first recognized AIDS outbreak occurs among New York heroin users, the first group injected with chimpanzee plasma. - 1974: Thirteen thousand New York gay men recruited to test the vaccines. - 1975: NYBC and Merck file three patents, citing five vaccine examples all made from pure chimpanzee antigens; a circular extraction method akin to dialysis to extract large amounts of antigens for mass production. - 1978: After years of testing, nationwide placebo-controlled trials begin on gay men with NYBC’s New York trial and CDC trials mainly in California; first HIV-positive blood samples found in gay men, all collected from the cohort, all of the never-before-seen subtype B. - 1979: September—ten months into the trial—the scientist in charge wants to abort due to an unexplainable flare-up in precisely 11 participants who received the vaccine; aborting would harm the vaccine’s reputation. CDC soon reports unexplainable Kaposi’s sarcoma cases in gay men, noting that precisely eleven had the flare-up as of September 1979; by December, 19 cases and the first death, marking the onset of the world's second AIDS outbreak affecting the second group inoculated with chimpanzee plasma-derived vaccines. - 1981: A cancer researcher suggests a new infectious agent with a 50% mortality rate may be causing Kaposi’s sarcoma cases in vaccine trial sites and claims it was transmitted in the vaccine as disease progression occurred quickly in trial participants; trial scientists confirm incubation periods differ and are longer in gay men not in the trial. In the next 15 months, another 593 cases emerge and 41% die. Merck announces Heptavax B, a third US brand for domestic market; original HBVax and NYBC B Vax offered only overseas; a compromise to get FDA approval makes the new version from human blood, but without the circular chimpanzee extraction method it’s “too expensive” for large-scale use. - 1982: CDC names the disease AIDS; CDC asserts the FDA-approved vaccine uses only human blood, distancing it from earlier vaccines; WHO warns AIDS may be caused by a virus in the vaccine’s plasma. - May 1983: French scientists identify the causal virus, enabling testing of archived blood samples; it was a chimpanzee virus, and KS lesions required co-infection with a second virus found in those chimpanzees. This discovery enables verifying the AIDS origin theory: vaccine transmission by comparing HIV rates between men randomly given the hepatitis B vaccine versus a placebo during the trials. Speaker 3 notes two pivotal events in their chimp vax preprint, now settled, and states that in June 1983 two Fauci-associated scientists claimed infection rates in the New York trial were similar between vaccine and placebo; internally, they say Fauci’s scientists spread disinformation to defend the chimpanzee vaccine invention. Speaker 2 contends that the CDC claimed no difference in rates in 1984 but that the private study remains unreleased; the analysis implies nearly all HIV infections occurred in vaccinated participants, not placebo, based on limited data and interpretation. The narrative argues the CDC private study would have shown high HIV rates among the vaccine group, but details were obscured. It alleges the CDC’s withheld study used skewed comparisons to mask vaccine-associated HIV transmission. Speaker 3 briefly references Africa’s rollout in 1984, claiming AIDS emerged there a year after a symposium and that FDA officials shifted from chimpanzee vaccines to the human-blood Heptavax, enabling continued overseas sales. It asserts chimpanzee-based vaccines were widely used in poor countries by 1986, with Africa’s initial infections concentrated in newborns and young women; the WHO suppressed findings that HIV spread via medical injections, not needles alone, to protect immunization programs. Retroactive testing allegedly shows HIV was not present in most African countries before vaccination; after vaccination began, infection rates rose in certain regions. The speaker notes a group, ChimpFacts, as a best account of probable HIV origins, but mainstream preprint servers rejected it.

Speaker 0 introduces Stefan Wencesl to discuss vaccine development, particularly the challenges of developing, adopting, and scaling vaccines for different variants and subvariants. Speaker 1 highlights the positive progress made in terms of manufacturing capacity, citing an example of producing 100,000 doors in 2019 and aiming to manufacture 1 billion doors the following year due to the anticipated pandemic.

The speaker states that organizations like the Gates Foundation are recommitting to global health initiatives. Despite challenges, there is optimism regarding the potential eradication of diseases like polio and malaria within the next twenty years, citing available tools and strategies. The Gates Foundation is pledging $1.6 billion to Gavi for the next five years and will invest billions more in developing new, low-cost vaccines to enhance Gavi's effectiveness. The speaker quotes Nelson Mandela on the importance of how a society treats its children, noting that Gavi has helped over one billion children live healthier lives in the last 25 years. Continued support is crucial to maintain this progress in the coming decades.

The speaker describes India as a laboratory to test ideas before taking them to other places. They state that they do more in India than any other country. An individual alleges that several Indian tribal girls were used as guinea pigs and that an untested vaccine was administered to thousands of tribal girls without proper study and paperwork. The Gates Foundation denied that it had been a clinical trial. The speaker mentions a commitment over the next decade to vaccines, and uses India as an example of a chaotic place with open defecation, stating that things won't be normal until there is an amazing vaccine for the entire world.

Speaker 1, a doctor, admits to working with 2 fetuses in their personal work related to vaccines. They confirm being an author of an article that involved 76 fetuses at the Wistar Institute. Various organs, including the pituitary gland, lung, skin, kidney, spleen, heart, and possibly the tongue, were harvested from these fetuses. The doctor cannot recall the exact number of fetuses they have worked with throughout their career but mentions studying them before using them for vaccine development. They are aware of objections to the use of aborted fetal tissue in vaccines, including religious concerns. The doctor stands by their statement that vaccinations are often criticized by religious zealots who believe that death and disease are part of God's will.

The speaker states that vaccines contained 40 different viruses that were being inactivated. The yellow fever vaccine contained leukemia virus due to the crude science of the time. The speaker says they were not reporting AIDS virus at the time, but they had a disease virus. The speaker says it was good science at the time because they didn't worry about these viruses.

In this video, the speaker talks about Vietnam and how there was no concept of autism in the country in 1975 and even in the years 2000 and 2001. They mention that when Vietnam signed agreements with the World Health Organization and the International Monetary Fund, the vaccination program was introduced by Bill Gates and the Gates Foundation. As a result, Vietnam has seen a significant increase of over 300% in some health issues.

Speaker 0 repeats two major statements he attributes to someone else: vaccines are the greatest return on investment I’ve ever had, and my number one goal and the biggest issue of our time is overpopulation. He asserts that this is not accidental, claiming that there is a Ted Talk in which the heart of the message is that through modern medicine and vaccines, we can reduce the population of the world. Speaker 1 adds data to the discussion by noting that the world today has 6,800,000,000 people, and that number is headed up to about 9,000,000,000. He states that if we do a really great job on new vaccines, health care, reproductive health services, we could lower that population by perhaps 10–15%. Speaker 0 then references the claim as something that “came out of his mouth,” acknowledging he is paraphrasing and not reproducing it exactly, but notes that they tried to retract it. He continues by saying that in the next video, the person is doing a whole thing on how we need to reduce the population of the world, arguing that there are too many people and that this abundance is causing the world’s problems. He emphasizes that when anyone questions these ideas, it can be labeled a conspiracy theory to say that vaccines are involved, prompting him to ask whether such labeling is accurate. Throughout the exchange, the speakers juxtapose vaccine benefits with population control rhetoric. The first speaker stresses that vaccines constitute a major return on investment and connects vaccines to reducing global population growth, while the second speaker provides projected population figures and suggests that vaccines, health care, and reproductive health services could modestly lower future population totals. The conversation also highlights disagreement over how these claims are presented and whether discussing population reduction in relation to vaccines constitutes a conspiracy theory.

The speaker discusses the challenges of delivering vaccines to remote areas, emphasizing the importance of overcoming obstacles to reach those in need. They highlight the significance of maternal immunization in protecting newborns and express optimism for closing the book on vaccine preventable diseases through innovation and collaboration with new partners. The speaker stresses the impact of vaccines on global health and the ongoing efforts to ensure access to life-saving immunizations worldwide.

In 02/2015, Bill Gates stated the world population needs to be reduced by 10 to 15% due to global warming, and this would be achieved through vaccines. In 02/2020, Gates said 7 billion people must be vaccinated. The speaker then poses the question of why they should take a vaccine for their health that is financed and produced by someone who wants to decrease the world population.

The head of the vaccine program, Dr. Stanley Plotkin, discusses the need for more post-authorization vaccine safety studies. He acknowledges the lack of proper safety studies before licensing vaccines and calls for more research to understand adverse reactions. Plotkin emphasizes the importance of identifying biological mechanisms of adverse reactions to develop safer vaccines. He highlights the slow progress in vaccine safety science and the need for adequate funding to address public concerns about vaccine safety. Ultimately, he urges for more comprehensive safety studies to ensure the safety of vaccines.

Charles Richet, a French researcher, received the Nobel Prize in 1913 for his work on anaphylaxis. According to the speaker, Richet's work demonstrates that vaccination is impossible. The speaker believes Richet was given the prize because he discovered how to poison people by sensitizing them to common environmental elements. Richet was a committed eugenicist, a fashionable attitude among the well-to-do at the time. The speaker claims that eugenicists were concerned with controlling the overbreeding of the poor classes, who lived in crowded conditions with poor hygiene. Instead of addressing these issues, they decided to vaccinate them. The speaker equates this to Bill Gates's work in Africa and India. The speaker asserts that eugenics never went away and that globalists still think of normal people in the same way, believing it is acceptable to poison, sterilize, and lie to people for the greater good. The speaker concludes that what started with Richet continues today.

The speaker discusses the development, adoption, and scaling of vaccines for different variants and subvariants. They highlight the speed and extraordinary process of vaccine development. They mention the availability of manufacturing capacity, with a reference to making 100,000 doses in 2019. The speaker recalls a conversation about the need to produce $1 billion worth of vaccines in the following year due to the predicted pandemic. The discussion briefly touches on the topic of new variants and subvariants before the transcript ends.